Cyrus Karkaria, PhD
Advertisement
Dr. Cyrus Karkaria is President of Lupin's Biotechnology Businesses, leading the company's global biosimilars portfolio with over 30 years of biologic drug development experience at organizations including Biogen, CuraGen, and Celldex Therapeutics. He holds a post-doctorate from Harvard Medical School and a PhD. from the University of Maryland.
Articles by Cyrus Karkaria, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Eyedaptic launches Eva, an agentic AI visual assistant for patients with retinal disease
2
Ophthalmic care uncommon after tamoxifen initiation
3
NeuroOp Guru: Flow-diverting stents and vision — safe or risky?
4
Global Summit for Eye Health 2026: Turning pledges into eye care
5